Ajay Kirtane on Muck Rack

Ajay Kirtane

As seen in: Color Research & Application, Nature, JAMA (The Journal of the American Medical Association), JAMA Surgery, JAMA: Journal of the American Medical Association, JAMA Cardiology, Healio, Healio Cardiac/Vascular Intervention, Healio Cardiology, NewsBreak and
Practicing Cardiologist, Professor @ColumbiaMed Researcher & advocate for thoughtful patient care; tweets≠endorsements nor med advice youtu.be/5Ppno9T0_Ko
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ajay

Contact Ajay, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FFRangio, are we ready for everyday practice?

|
By Rasha Al-Lamee cardiologist, William F. Fearon, Ajay Kirtane
| PCR Online
Participate in this live event Register with your My PCR account, add it to your calendar and receive automatic reminders.
Open in Who Shared Issue with article?

Renal Denervation in 2025: What the Latest Data, Guideline and NCD Mean for Your Practice

|
By Sripal Bangalore, Ajay Kirtane, Behnam M Tehrani, Luke J. Laffin
| RadcliffeCardiology.com
Published: Likes: 0 Share: Average (ratings) Learning Objectives Describe guideline recommendations for renal denervation (RDN) Recall recent clinical trial data and real-world evidence for RDN Apply an evidence-based approach to patient selection for RDN Use expert experience to optimise RDN therapy in real-world practice Target Audience Cardiologists Interventionalists Hypertension Specialists More from this programme Dr Sripal Bangalore introduces the session and the panel.
Open in Who Shared Issue with article?

Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis

|
By Ajay Kirtane, Richard A Shlofmitz, Jeffrey W. Moses, William Bachinsky
| JACC (Journal of the American College of Cardiology)
Abstract Patients with coronary in-stent restenosis (ISR) within multiple layers of stent pose a specific clinical challenge because of higher rates of recurrent restenosis as well as a desire to avoid an additional layer of stent. Drug-coated balloons (DCBs) provide an alternative antiproliferative therapeutic option for multilayer ISR.
Open in Who Shared Issue with article?
See all 85 licensed articles (87 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Ajay

Contact Ajay, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified